1. Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting
- Author
-
Young-Cheoul Doo, Chong-Yun Rim, Seung-Hyuk Choi, Kyung-Soon Hong, Sang-Jin Han, Yung Lee, Goo Yeong Cho, Dong-Jin Oh, Kwang-Hahk Lee, Sung-Woo Han, Kyu-Hyung Ryu, Kyoo-Rok Han, Woo-Jung Park, and Namho Lee
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Statin ,medicine.drug_class ,medicine.medical_treatment ,Clinical Investigations ,Gastroenterology ,Statistics, Nonparametric ,Group B ,chemistry.chemical_compound ,Internal medicine ,medicine ,Humans ,Angina, Unstable ,cardiovascular diseases ,Interleukin 6 ,Chi-Square Distribution ,biology ,Interleukin-6 ,business.industry ,Unstable angina ,C-reactive protein ,Stent ,General Medicine ,Middle Aged ,Intercellular Adhesion Molecule-1 ,medicine.disease ,Coronary Vessels ,Lipoproteins, LDL ,C-Reactive Protein ,chemistry ,Low-density lipoprotein ,Immunology ,biology.protein ,Female ,Stents ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Lipoprotein - Abstract
Background: Statins are believed to reduce coronary heart disease by mechanisms in addition to their well-known cholesterol lowering effect. Hypothesis: We studied the effect of statins on expression of C-reactive protein (CRP), interleukin-6 (IL-6), adhesion molecules, and antioxidized low-density lipoprotein antibody (anti-oxLDL Ab) in patients with unstable angina (Braunwald class IIb or IIIb) undergoing coronary stenting. Methods: Consecutive 50 patients with unstable angina were included in the study. We classified the study subjects as patients using statins (Group A, n = 20, men 10, mean age 62 years) and patients notusing statins (Group B, n= 30, men 15, mean age 60 years). Results: Baseline levels of inflammatory markers were similar in the two groups. However, 24 h after coronary stenting, serum levels of CRP (2.00 vs. 4.63 mg/l, p < 0.05), intercellular adhesionmolecule-1 (ICAM-1) (217 vs. 261 ng/ml, p
- Published
- 2005